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Summary  Streptococcus  mutans  is  an  important  cariogenic  microorganism,  and
alternative  methods  for  its  elimination  are  required.  Different  concentrations  of
Baccharis  dracunculifolia  essential  oil  (EO)  were  tested  to  determine  its  minimal
inhibitory  concentration  (MIC)  in  planktonic  cultures,  and  this  concentration  was
used  in  S.  mutans  bioﬁlms.  Additionally,  we  assessed  the  effect  of  a  0.12%  chlorhex-
idine  (CHX)  and  saline  solution  in  S.  mutans  bioﬁlms.  The  bioﬁlms  were  grown  in
discs  of  composite  resin  for  48  h  and  exposed  to  B.  dracunculifolia,  CHX  or  saline
solution  for  5  min.  The  viability  of  the  bioﬁlms  was  determined  by  counting  the
colony-forming  units  per  milliliter  (CFU/ml)  in  agar,  which  was  statistically  signif-
icant  (P  <  0.05).  The  MIC  of  the  B.  dracunculifolia  EO  to  planktonic  growth  of  S.
mutans  was  6%.  In  bioﬁlms  of  S.  mutans  clinical  isolates,  B.  dracunculifolia  EO  (6%)
and  CHX  resulted  in  reductions  of  53.3—91.1%  and  79.1—96.6%,  respectively.  For  the
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 bioﬁlm  is  a  naturally  occurring  accumulation
f microorganisms  of  either  a  single  or  multiple
pecies embedded  in  an  extracellular  polymeric
atrix and  adherent  to  a  biologic  or  non-biologic
urface. Bacteria  in  a  bioﬁlm  differ  profoundly
rom their  planktonic  counterparts  by  growing  in  an
nclosed, nutrient-sufﬁcient  ecosystem  as  a com-
unity of  sessile  organisms  that  exhibit  an  altered
henotype  with  respect  to  the  growth  rate,  gene
ranscription  [1], and  resistance  to  antimicrobial
gents [2].  The  resistance  of  bioﬁlms  to  antibi-
tics is  increased  compared  with  planktonic  cells.  In
act, when  cells  exist  in  a  bioﬁlm,  they  can  become
0—1000  times  more  resistant  to  the  effects  of
ntimicrobial agents  [3—5].
The oral  cavity  is  heavily  colonized  by  a  complex,
elatively speciﬁc  and  highly  interrelated  range  of
icroorganisms,  which  are  organized  in  bioﬁlms.
here  is  substantial  evidence  linking  oral  disease
nd respiratory  tract  infections  with  the  pathogens
n oral  bioﬁlms  [6].
Approximately  20%  of  oral  bacteria  are  strep-
ococci [7].  The  oral  streptococci  pioneer  early
ental plaque  formation  and  have  a  speciﬁc  tem-
oral  and  spatial  distribution  that  is  crucial  for
he development  of  oral  bioﬁlms.  Streptococcus
utans is  considered  to  be  the  most  cariogenic
f all  oral  streptococci  [8],  and  the  main  factors
ssociated with  its  cariogenicity  include  adhesion,
cidogenicity and  acid  tolerance  [9,10].  These  bac-
eria produce  glucosyltransferases  and  synthesize
lucans from  sucrose,  which  mediate  the  adherence
f S. mutans  and  other  oral  bacterial  microbiota
n tooth  surfaces,  contributing  to  the  formation
f dental  bioﬁlm.  Selection  for  a  cariogenic  micro-
iota  in  dental  bioﬁlm  increases  the  magnitude
f the  decrease  in  pH  following  the  fermentation
f available  carbohydrates  as  well  as  increases
he probability  of  enamel  demineralization,  which
eads to  the  formation  of  dental  caries  [9].
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tans  reference  strain,  the  reductions  achieved  with  B.
were,  respectively,  39.3%  and  88.1%.  It  was  concluded
owed  antibacterial  activity  and  was  able  to  control  this
therwise  causes  dental  caries.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
Bioﬁlms  must  be  removed  mechanically,  but
ntibacterial mouth  rinses  are  effective  at  decreas-
ng tooth  surface  bioﬁlms.  In  general,  mouth
inses contain  ﬂuorides,  alcohols,  and  detergents
r antibacterial  substances  [11]. Ideal  antibacte-
ial substances  must  be  effective  against  many
icroorganisms,  act  rapidly,  maintain  activity  at
ow concentrations,  lack  side  effects,  and  not
ause discomfort  [12]. Frequently  used  antibacte-
ial chemicals  include  povidone  iodine  products,
hlorhexidine, and  cetylpyridinium  chloride  [13].
owever, natural  products  have  signiﬁcantly  con-
ributed to  the  discovery  of  chemical  structures
nd the  creation  of  new  medicaments  that  can  be
sed as  innovative  therapeutic  agents  against  this
revalent disease  [14,15]
Baccharis  dracunculifolia  DC  (Asteraceae)  is  a
ative plant  from  Brazil,  which  is  commonly  known
s ‘‘alecrim-do-campo’’’  and  ‘‘vassoura’’.  B.  dra-
unculifolia  is  the  most  important  botanical  source
f South-eastern  Brazilian  propolis,  known  as  green
ropolis because  of  its  color  [16].  Teas,  decoctions
nd tinctures  prepared  from  the  ﬂowering  plant  are
idely used  in  alternative  medicine  to  treat  inﬂam-
ation, hepatic  disorders  and  stomach  ulcers  [17].
 variety  of  chemical  compounds  and  pharmaco-
ogical activities  have  been  attributed  to  this  plant,
ncluding antiulcerative  [18],  antibacterial  [19]  and
ntifungal [20]  properties.
The  aim  of  this  study  was  to  determine  the
inimal inhibitory  concentration  (MIC)  of  B. dra-
unculifolia  essential  oil  (EO)  against  planktonic
ultures of  S.  mutans  and  its  antibacterial  activity
n bioﬁlms  formed  in  the  discs  of  composite  resin.
aterials and methods
icroorganisms and standard suspensionseven  S.  mutans  strains  that  had  been  previ-
usly isolated  and  identiﬁed  from  the  oral  cavities
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of  healthy  individuals  and  one  reference  strain
(American Type  Culture  Collection  —  ATCC® 35688,
Manassas, USA)  of  S.  mutans  that  was  maintained
in our  laboratory  stock  collection  were  included  in
the study.
Standard  suspensions  of  each  isolate,  containing
106 cells/ml,  were  prepared.  For  this  purpose,  iso-
lates were  seeded  onto  brain  heart  infusion  (BHI)
agar (Difco,  Detroit,  USA)  and  incubated  for  48  h.
All incubations  were  performed  37 ◦C  and  at a
partial pressure  of  5%  CO2. After  incubation,  the
cells were  suspended  in  sterile  saline  solution  [0.9%
sodium  chloride  (NaCl)],  and  the  number  of  cells
in suspension  was  counted  with  a  spectrophotome-
ter (B582,  Micronal,  São  Paulo,  Brazil).  The  optical
density  and  wavelength  were  0.620  and  398  nm,
respectively.
Essential oil isolation
Leaves  of  the  B.  dracunculifolia  plant  were  col-
lected from  the  region  of  Belo  Horizonte,  Minas
Gerais, Brazil  to  extract  EO.  The  plant  sample  was
identiﬁed,  and  a  voucher  specimen  was  deposited
in the  herbarium  of  the  Zoobotanic  Foundation,
which was  localized  in  the  same  city.  Air-dried  plant
leaves were  placed  in  a  round-bottom  distillation
ﬂask to  which  distilled  water  was  added.  The  EO
was obtained  by  hydrodistillation  for  3  h  with  Cle-
venger apparatus  [20]. The  EO  was  separated,  dried
over anhydrous  sodium  sulfate,  and  stored  in  an
amber bottle  at  4 ◦C  until  used.
Determination of the minimal inhibitory
concentrations (MIC) of essential oil
The  MIC  of  B.  dracunculifolia  EO  was  determined
by the  microdilution  in  broth  method  in  sterile  96-
well ﬂat-bottom  microtiter  plates  with  a lid  (Costar
Corning, New  York,  USA).  Different  concentrations
of B.  dracunculifolia  EO  were  prepared  by  dis-
solving various  amounts  of  EO  in  distilled  water.
Tween-80 (0.05%,  v/v)  was  added  to  enhance  oil
the solubility.  The  dilutions  were  sterilized  in  dis-
posable membrane  ﬁlters  with  a  0.22-m  pore  size
(Millipore,  São  Paulo,  Brazil).  A  total  of  0.1  ml  of
each dilution  of  B.  dracunculifolia  EO  and  0.1  ml  of
bacterial standard  suspensions,  as  described  above,
were used  in  each  test,  and  the  mixtures  were  incu-
bated for  48  h  at  37 ◦C.  Each  sample  was  tested
in duplicate.  The  lowest  concentration  of  B.  dra-
cunculifolia  EO  required  to  completely  inhibit  the
growth  of  S.  mutans  was  designated  as  the  MIC.  The
MIC was  used  in  the  experiments  that  evaluated  the
viability  of  S.  mutans  bioﬁlms.
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roduction of bioﬁlms and antibacterial
ssays
he  bioﬁlm  formation  was  developed  as  a  method-
logy proposed  by  Pereira  et  al.  [21]. The  bioﬁlms
ere grown  on  240  sterile  discs  (30  for  each  iso-
ate) of  composite  resin,  which  were  prepared  in
 cylindrical-shaped  Teﬂon  mold  that  was  6.0  mm
n diameter  and  3.00  mm  in  height.  The  mold  was
lled in  a single  increment  with  microhybrid  (Vit-l-
scenceTM, Ultradent  Products,  South  Jordan,  USA)
nd covered  with  a  mylar  matrix  strip.  The  top
urface was  cured  for  40  s  in  a  curing  unit  device
Optilux 401,  Demetron/Kerr,  Danbury,  CT,  USA)
hat was  operating  between  700  and  800  mW/cm2.
amples were  retrieved  from  the  mold,  and  the
xcess resin  was  removed  with  surgical  blades.  The
iscs were  immersed  in  distilled  water  at  37 ◦C  and
terilized  by  autoclaving  at  121 ◦C  for  15  min.
The discs  were  placed  in  24-well  plates  (Costar
orning, New  York,  USA)  with  2  ml  of  sterile  Gibbons
nd Nygaard  broth  [22]. The  wells  were  inoculated
ith 0.1  ml  of  standard  suspensions,  and  the  plates
ere incubated  for  48  h. The  broth  was  changed
fter 24  h  of  incubation.
After 48  h of  incubation,  the  discs  containing
he bioﬁlms  were  washed  twice  with  0.9%  NaCl  to
emove loosely  bound  material,  and  they  were  sub-
itted to  antibacterial  assays.  The  antibacterial
ffects of  B.  dracunculifolia  EO  in  the  concen-
ration of  6%  (MIC  obtained)  were  evaluated.  The
.9% NaCl  was  used  as  a  negative  control,  and
.12% chlorhexidine  (CHX)  solution  (Byoformula,
ão Paulo,  Brazil)  was  used  as  a positive  control.
The 240  discs  (30  for  each  isolate)  with  bioﬁlms
stablished after  48  h were  treated  for  5 min  with
 ml  of  B.  dracunculifolia  EO  (n  =  10),  0.12%  CHX
n =  10)  and  sterile  0.9%  NaCl  (n  = 10).
After the  experimental  periods,  each  bioﬁlm  was
ashed  with  2 ml  of  0.9%  NaCl  to  remove  the  tested
ubstances. The  discs  were  placed  in  tubes  con-
aining  10  ml  of  0.9%  NaCl  and  they  were  sonicated
Sonoplus HD  2200,  50  W.  Bandelin  Eletronic,  Berlin,
ermany)  for  30  s  to  disperse  the  bioﬁlms.  Bioﬁlm
uspensions  were  serially  diluted  in  0.9%  NaCl  to
ive dilutions  of  10−1 to  10−5 times  the  original
oncentration.  One  hundred  microliter  aliquots  of
ach dilution  were  seeded  on  BHI  agar  (in  dupli-
ate). After  48  h  of  incubation,  the  number  of
olony-forming  units  per  milliliter  (CFU/ml)  was
etermined.  The  results  were  analyzed  by  analysis
f variance  (ANOVA)  and  the  Tukey  test.  A  P value
0.05 was  considered  to  indicate  a statistically  sig-
iﬁcant difference.  The  percentage  of  reduction
as calculated  with  0.9%  NaCl  results  as  a  refer-
nce.
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Figure  1  The  mean  and  standard  deviation  of  the
CFU/ml  (105)  obtained  in  the  three  experimental  con-
ditions  tested  for  bioﬁlms  formed  by  S.  mutans  clinical
strains,  B.  dracunculifolia  essential  oil  (6%),  chlorhex-
idine  (0.12%),  and  physiological  solution  (0.9%  NaCl).
Tukey  test  for  each  tested  group.  The  values  followed
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Table  1  Means  and  standard  deviation  of  reduc-
tions  for  bioﬁlms  formed  by  each  strain  of  S.  mutans,
treated  with  B.  dracunculifolia  essential  oil  (6%)  or
chlorhexidine  (0.12%),  compared  with  the  control
group,  that  was  treated  only  with  physiological  solu-
tion  (NaCl  0.9%).
Bioﬁlms  formed  by  Bioﬁlms  reductions  with
B.  dracunculi-
folia  essential
oil  (6%)
Chlorhexidine
(0.12%)
Clinical  strain  15 53.3%  ±  21.4% 88.1%  ±  13.5%
Clinical  strain  22 78.9%  ±  9% 79.1%  ±  11.9%
Clinical  strain  24  90.9%  ±  5%  91.7%  ±  11.4%
Clinical  strain  26  71.8%  ±  24.5%  80%  ±  21%
Clinical  strain  28  91.1%  ±  4.9%  96.6%  ±  3.1%
Clinical  strain  29  75%  ±  15.9%  90.6%  ±  3.2%
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Sy  different  capital  letters  differed  signiﬁcantly  between
he  tested  experimental  conditions.
esults
n  this  study,  we  initially  determined  the  lowest
oncentration of  B.  dracunculifolia  EO  required  to
ompletely  inhibit  the  growth  of  S.  mutans  in  plank-
onic cultures,  which  was  designated  as  the  MIC.
he MIC  of  the  B.  dracunculifolia  EO  to  S.  mutans,
oth  standard  and  clinical  strains,  was  6%.  This
oncentration  was  used  in  subsequent  assays  to
valuate  the  viability  of  the  S.  mutans  bioﬁlms.
The mean  and  standard  deviation  values  of  the
FU/ml  (105)  obtained  in  the  three  experimen-
al conditions  for  each  bioﬁlm  group  are  shown  in
igs.  1  and  2.  Signiﬁcant  decreases  in  the  viabil-
ty of  bioﬁlms  formed  by  S.  mutans  clinical  isolates
reated  with  B.  dracunculifolia  (P  =  0.0254)  and
HX (P  =  0.0038)  were  observed  compared  to  the
igure  2  The  mean  and  standard  deviation  of  the
FU/ml  (105)  obtained  in  the  three  experimental  con-
itions  tested  for  bioﬁlms  formed  by  the  S.  mutans
eference  strain,  B.  dracunculifolia  essential  oil  (6%),
hlorhexidine  (0.12%),  and  physiological  solution  (0.9%
aCl).  The  Tukey  test  for  each  tested  group.  Values  fol-
owed  by  different  capital  letters  differed  signiﬁcantly
etween  the  tested  experimental  conditions.
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tClinical  strain  31  61.7%  ±  20.6%  84.8%  ±  10.9%
Reference  strain  39.3%  ±  17.5%  88.1%  ±  13.4%
ontrol  group  (treated  with  0.9%  NaCl  only).  In
ioﬁlms formed  by  the  S.  mutans  reference  strain,
reatment  with  B.  dracunculifolia  (P  =  0.0032)  and
HX (P  = 0.0001)  also  promoted  signiﬁcant  reduc-
ions in  the  viability.
The  means  of  reduction  for  bioﬁlms  formed  by
ach strain  treated  with  B.  dracunculifolia  EO  or
HX, compared  to  the  untreated  controls  bioﬁlms,
re shown  in  Table  1.
iscussion
.  mutans  is  an  important  microorganism  for  early
olonization  on  tooth  surfaces  during  the  formation
f a dental  plaque  [23]. The  acidogenic  properties
f S.  mutans,  in  addition  to  its  ability  to  synthe-
ize extracellular  glucans,  are  the  major  factors
nvolved in  the  development  and  establishment  of
ariogenic bioﬁlms  [24]. Various  chemical  plaque
ontrol  approaches  have  been  suggested  to  reduce
ariogenic  bioﬁlms.  Among  them,  CHX  and  tri-
losan, which  are  synthetic  chemical  antimicrobial
gents, are  common  materials  in  oral  care  prod-
cts [25,26]. Although  these  compounds  have  broad
nd strong  antibacterial  characteristics,  they  have
ong-term  side  effects,  such  as  intra-oral  staining
nd disturbance  of  the  oral  bacterial  ecology  [27].
herefore, there  has  been  increasing  attention  on
he discovery  of  new  compounds  that  lack  side
ffects with  long-term  use.
The aim  of  this  study  was  to  evaluate  the  activityf B.  dracunculifolia  EO  against  planktonic  cul-
ures, bioﬁlms  of  reference  (ATCC)  and  clinical
trains of  S.  mutans.  In  S.  mutans  planktonic  cul-
ures, the  effective  concentration  that  could  inhibit
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the  growth  of  the  strains  was  6%.  This  concentra-
tion was  used  in  subsequent  assays  to  evaluate  the
viability of  S.  mutans  bioﬁlms  and  resulted  in  sig-
niﬁcant reductions  in  the  viability  of  these  bioﬁlms
without  total  elimination.  In  bioﬁlms  formed  by  S.
mutans clinical  isolates,  B.  dracunculifolia  EO  pro-
duced reductions  of  53.3  ±  21.4%  to  91.1  ±  4.9%.
For the  bioﬁlm  formed  by  the  S.  mutans  reference
strain, the  reduction  achieved  with  B.  dracunculi-
folia EO  was  of  39.3  ±  17.5%.
The presence  of  microbial  bioﬁlms  is  the  main
cause of  inefﬁcient  eradication  with  antibiotic
therapy. Bioﬁlm  bacteria  often  tolerate  antibiotic
doses that  are  several  100-fold  over  the  mini-
mum lethal  dose  for  bacteria  living  outside  the
bioﬁlm [4].  The  mechanism  of  bioﬁlm  resistance
includes physical  or  chemical  diffusion  barriers  to
antimicrobial  penetration  into  the  bioﬁlm,  slow
growth  of  the  bioﬁlm  from  nutrient  limitation,
activation of  the  general  stress  response  and
the emergence  of  a  bioﬁlm-speciﬁc  phenotype
[28].  These  issues  have  made  it  necessary  to
develop alternative  strategies  to  control  bioﬁlms,
particularly  in  the  context  of  treating  oral  dis-
ease.
Selected natural  products  that  originate  in  plants
can inﬂuence  microbial  bioﬁlm  formation.  Plant-
derived  compounds  inhibit  peptidoglycan  synthesis
[29],  damage  microbial  membrane  structures  [30],
modify bacterial  membrane  surface  hydrophobic-
ity [31]  and  modulate  quorum  sensing  [29], all
of which  could  inﬂuence  bioﬁlm  formation.  The
mechanisms  by  which  EO  can  inhibit  microorgan-
isms involve  different  modes  of  action  and  may  be
due, in  part,  to  their  hydrophobicity.  As  a  result,
the oils  are  partitioned  into  the  lipid  bilayer  of  the
cell membrane,  affecting  the  respiratory  chain  and
leading to  the  leakage  of  vital  cell  contents  [32].
The impairment  of  bacterial  enzyme  systems  may
also be  a  potential  mechanism  of  action.  Various
components of  EO  can  permeabilize  the  cell  mem-
brane,  increasing  the  penetration  of  antibiotics.
Interference  with  the  bacterial  enzyme  systems
may be  another  potential  mechanism  of  action
[33].
The antimicrobial  activity  of  B.  dracunculifolia
EO found  in  this  study  may  be  due  to  the  presence  of
high prenylated  p-coumaric  acid  levels,  primarily  of
artepillin C  and  baccharin,  ﬂavonoids,  diterpenes,
and triterpenes  isolated  from  the  aerial  parts  of  the
plant [34,35]. Leitão  et  al.  [36]  veriﬁed  that  green
propolis and  B.  dracunculifolia  extracts  have  a bac-
teriostatic  effect  on  the  planktonic  cultures  of  S.
mutans as  well  as  have  inhibitory  effects  on  the
cariogenic  traits  (glucan  synthesis  and  acidogenic
potential) exhibited  by  these  bacteria.  The  leaves
E
NC.A.  Pereira  et  al.
f  B.  dracunculifolia  have  also  exhibited  antifungal
ctivity  against  Candida  spp.  [20]. A  clinical  study
valuated  the  efﬁcacy  of  green  propolis,  collected
y Apis  mellifera  bees  from  B.  dracunculifolia,
n treating  patients  diagnosed  with  gingivitis  and
hronic periodontitis,  observing  regression  of  these
iseases [37].  Another  relevant  study  conducted  by
esende et  al.  [38]  noted  the  absence  of  mutagenic
ctivity of  B.  dracunculifolia  extracts  and  Artepillin
 using  Salmonella  typhimurium  strains.
In the  present  study,  CHX  was  used  as  a nega-
ive control,  and  there  were  signiﬁcant  reductions
n the  viability  of  S.  mutans  bioﬁlms.  In  bioﬁlms
ormed by  S.  mutans  clinical  isolates,  CHX  had
eductions  of  79.1  ±  11.9%  to  96.6  ±  3.1%.  For
he bioﬁlm  formed  by  the  S.  mutans  reference
train, the  reduction  achieved  with  CHX  was  of
8.1 ±  13.4%.  These  ﬁndings  agree  with  the  lit-
rature  on  the  action  of  CHX  on  aerobic  and
naerobic Gram-positive  and  Gram-negative  bac-
eria and  yeast.  This  chemical  substance  has  a
igh afﬁnity  for  the  cell  wall  of  microorganisms,
nd it induces  cell  surface  alterations  that  cause
he loss  of  osmotic  balance  and  cytoplasmic  pre-
ipitation  [39].  Currently,  CHX  is  the  safest  and
ost  efﬁcient  antimicrobial  agent  for  reducing  the
icroorganisms  in  the  oral  cavity.  However,  CHX  is
ssociated with  a number  of  adverse  effects,  such
s the  formation  of  stains  on  teeth  and  dentures,
ysgeusia, parotid  enlargement,  and  desquama-
ion of  the  oral  mucosa  [40]. These  factors  have
ncouraged  the  search  for  other  antimicrobial
gents.
Based on  the  current  results,  it  can  be  concluded
hat B.  dracunculifolia  EO  was  effective  at  reduc-
ng the  viability  of  S.  mutans  bioﬁlms.  In  addition,
n planktonic  cultures,  B.  dracunculifolia  EO  was
ble to  inhibit  the  complete  growth  of  S.  mutans.
hese  data  indicate  its  usefulness  for  controlling
ral microorganisms  that  cause  of  dental  caries.
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